MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0027090
Mederal Pharmaceuticals Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹12.25 Cr
▲ 36% YoY
Net profit · FY 2025
₹8.18 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹11.75 Lakh
EBITDA margin 1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
2
of 4 registered
About Mederal Pharmaceuticals Private Limited
Data last updated:
Mederal Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 24 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24302MH2018PTC308447. Its GSTIN is 27AALCM7939A1Z9 (Maharashtra). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Dhaval Dhirajlal Akbari and Nitinn Satyendra Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.25 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹8.18 Lakh (net margin 0.7%) and EBITDA of ₹11.75 Lakh (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 65% over three years and 23% over five years.
The company is associated with 1 brand: Mederal Pharmaceuticals.
Mederal Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0027090). For more details, the company can be reached via its website mederalpharmaceuticals.com.
Company details
CIN U24302MH2018PTC308447
Registration Number 308447
Incorporation Date 24 April 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-MH-18-0027090
Recognitions & Rankings of Mederal Pharmaceuticals
Contact details
Mederal Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is mederalpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSh No 169 Raghuleela Mega Mall Bhd Poisar Bus Depot Borsa Papa Rd Poisa, R Borivali, Mumbai, Maharashtra, India – 400067
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Mederal Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Mederal Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Mederal Pharmaceuticals operates one associated brand: Mederal Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Serves as an online supplier of medical instruments for healthcare organizations. | mederalpharmaceuticals.com |
Business activity
The main business activities of Mederal Pharmaceuticals are manufacturing and support service to organizations. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other support services to organizations. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Mederal Pharmaceuticals Private Limited, buy the company report.
Financials of Mederal Pharmaceuticals Private Limited
FY 2025 filings availableMederal Pharmaceuticals Private Limited reported revenue of ₹12.25 Cr (up 36% YoY) for FY 2025.
Revenue · FY 2025
₹12.25 Cr ▲ 36%
Net profit · FY 2025
₹8.18 Lakh margin 0.7%
EBITDA · FY 2025
₹11.75 Lakh margin 1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 65%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▲ 27%
3 years · compounded
▲ 61%
5 years · compounded
▲ 29%
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 36% growth in the latest year. EBITDA rose 27% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mederal Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mederal Pharmaceuticals Private Limited
Mederal Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhaval Dhirajlal Akbari | Director | 24 Apr 2018 | 8 Years 6 Months | Current |
| Nitinn Satyendra Gupta | Director | 24 Apr 2018 | 8 Years 6 Months | Current |
Peer comparison
Mederal Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avicura Pharmaceuticals Private Limited | ₹12.32 Cr (FY 2025) | 5.0% | Thane, Maharashtra, India | |||
| Mederal Pharmaceuticals Private Limitedthis company | ₹12.25 Cr (FY 2025) | ₹8.18 Lakh | 0.7% | 36.0% | Mumbai, Maharashtra, India | |
| Tanishka Pharmaceuticals Private Limited | ₹12.13 Cr (FY 2025) | -14.0% | Solan, Himachal Pradesh, India | |||
| Alithia Pharmaceuticals Private Limited | ₹12.08 Cr (FY 2025) | 292.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Mederal Pharmaceuticals Private Limited, buy the company report.
Auditor
Mederal Pharmaceuticals Private Limited is audited by HITESH H SHAH & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HITESH H SHAH & ASSOCIATES | FY 2023 | 140908W |
Shareholding
The shareholding of Mederal Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mederal Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mederal Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mederal Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mederal Pharmaceuticals has 4 GST registrations: 2 active and 2 cancelled or inactive.
Total GSTINs
4
Active
2
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCM7939A1Z9 | Maharashtra | Active | 15 Jun 2018 |
| 24AALCM7939A1ZF | Gujarat | Active | 31 Oct 2018 |
To see the full GST registrations and return filing status of Mederal Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mederal Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Maganbhai Gordhanbhai Lunagaria ceased to be Director on 24 Feb 2023.
AGM
Mederal Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Mederal Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Maganbhai Gordhanbhai Lunagaria ceased to be Director.
Appointed
Dhaval Dhirajlal Akbari was appointed as Director.
Appointed
Nitinn Satyendra Gupta was appointed as Director.
Incorporation
24 Apr 2018
Mederal Pharmaceuticals Private Limited was registered on 24 Apr 2018 with Roc Mumbai & aged 8 years 6 months as per MCA records.
Frequently asked questions
Mederal Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 24 April 2018 (8+ years old) and is registered under CIN U24302MH2018PTC308447.
Mederal Pharmaceuticals has 2 current directors:
- Dhaval Dhirajlal Akbari - Director
- Nitinn Satyendra Gupta - Director
The latest financial statements of Mederal Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Mederal Pharmaceuticals is 27AALCM7939A1Z9, registered in Maharashtra. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 24AALCM7939A1ZF (Gujarat).
The CIN (Corporate Identification Number) of Mederal Pharmaceuticals is U24302MH2018PTC308447. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mederal Pharmaceuticals was incorporated on 24 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Mederal Pharmaceuticals by revenue are Avicura Pharmaceuticals Private Limited, Tanishka Pharmaceuticals Private Limited, Alithia Pharmaceuticals Private Limited, all in the Healthcare industry (Medical and Laboratory Equipment, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Maganbhai Gordhanbhai Lunagaria ceased to be Director on 24 Feb 2023. Dhaval Dhirajlal Akbari was appointed as Director on 24 Apr 2018. Nitinn Satyendra Gupta was appointed as Director on 24 Apr 2018.
Yes, Mederal Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0027090).
Mederal Pharmaceuticals can be reached through the website mederalpharmaceuticals.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Mederal Pharmaceuticals is at Sh No 169 Raghuleela Mega Mall Bhd Poisar Bus Depot Borsa Papa Rd Poisa, R Borivali, Mumbai, Maharashtra, India – 400067.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages